Development of an Inflammatory CD14+ Dendritic Cell Subset in Humanized Mice
Humanized mouse models are attractive experimental models for analyzing the development and functions of human dendritic cells (DCs) in vivo. Although various types of DC subsets, including DC type 3 (DC3s), have been identified in humans, it remains unclear whether humanized mice can reproduce hete...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.643040/full |
id |
doaj-28c899af954d40e2a23063a04dfd20a9 |
---|---|
record_format |
Article |
spelling |
doaj-28c899af954d40e2a23063a04dfd20a92021-03-15T05:48:32ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-03-011210.3389/fimmu.2021.643040643040Development of an Inflammatory CD14+ Dendritic Cell Subset in Humanized MiceRyutaro Iwabuchi0Ryutaro Iwabuchi1Ryutaro Iwabuchi2Keigo Ide3Keigo Ide4Kazutaka Terahara5Ryota Wagatsuma6Rieko Iwaki7Hiroko Matsunaga8Yasuko Tsunetsugu-Yokota9Yasuko Tsunetsugu-Yokota10Haruko Takeyama11Haruko Takeyama12Haruko Takeyama13Haruko Takeyama14Yoshimasa Takahashi15Department of Immunology, National Institute of Infectious Diseases, Tokyo, JapanDepartment of Life Science and Medical Bioscience, Waseda University, Tokyo, JapanComputational Bio Big-Data Open Innovation Laboratory, National Institute of Advanced Industrial Science and Technology, Tokyo, JapanDepartment of Life Science and Medical Bioscience, Waseda University, Tokyo, JapanComputational Bio Big-Data Open Innovation Laboratory, National Institute of Advanced Industrial Science and Technology, Tokyo, JapanDepartment of Immunology, National Institute of Infectious Diseases, Tokyo, JapanDepartment of Life Science and Medical Bioscience, Waseda University, Tokyo, JapanDepartment of Immunology, National Institute of Infectious Diseases, Tokyo, JapanResearch Organization for Nano and Life Innovation, Waseda University, Tokyo, JapanDepartment of Immunology, National Institute of Infectious Diseases, Tokyo, JapanDepartment of Medical Technology, School of Human Sciences, Tokyo University of Technology, Tokyo, JapanDepartment of Life Science and Medical Bioscience, Waseda University, Tokyo, JapanComputational Bio Big-Data Open Innovation Laboratory, National Institute of Advanced Industrial Science and Technology, Tokyo, JapanResearch Organization for Nano and Life Innovation, Waseda University, Tokyo, JapanInstitute for Advanced Research of Biosystem Dynamics, Waseda Research Institute for Science and Engineering, Waseda University, Tokyo, JapanDepartment of Immunology, National Institute of Infectious Diseases, Tokyo, JapanHumanized mouse models are attractive experimental models for analyzing the development and functions of human dendritic cells (DCs) in vivo. Although various types of DC subsets, including DC type 3 (DC3s), have been identified in humans, it remains unclear whether humanized mice can reproduce heterogeneous DC subsets. CD14, classically known as a monocyte/macrophage marker, is reported as an indicator of DC3s. We previously observed that some CD14+ myeloid cells expressed CD1c, a pan marker for bona fide conventional DC2 (cDC2s), in humanized mouse models in which human FLT3L and GM-CSF genes were transiently expressed using in vivo transfection (IVT). Here, we aimed to elucidate the identity of CD14+CD1c+ DC-like cells in humanized mouse models. We found that CD14+CD1c+ cells were phenotypically different from cDC2s; CD14+CD1c+ cells expressed CD163 but not CD5, whereas cDC2s expressed CD5 but not CD163. Furthermore, CD14+CD1c+ cells primed and polarized naïve CD4+ T cells toward IFN-γ+ Th1 cells more profoundly than cDC2s. Transcriptional analysis revealed that CD14+CD1c+ cells expressed several DC3-specific transcripts, such as CD163, S100A8, and S100A9, and were clearly segregated from cDC2s and monocytes. When lipopolysaccharide was administered to the humanized mice, the frequency of CD14+CD1c+ cells producing IL-6 and TNF-α was elevated, indicating a pro-inflammatory signature. Thus, humanized mice are able to sustain development of functional CD14+CD1c+ DCs, which are equivalent to DC3 subset observed in humans, and they could be useful for analyzing the development and function of DC3s in vivo.https://www.frontiersin.org/articles/10.3389/fimmu.2021.643040/fullhumanized micedendritic cellDC3CD14inflammatory responseS100A8 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ryutaro Iwabuchi Ryutaro Iwabuchi Ryutaro Iwabuchi Keigo Ide Keigo Ide Kazutaka Terahara Ryota Wagatsuma Rieko Iwaki Hiroko Matsunaga Yasuko Tsunetsugu-Yokota Yasuko Tsunetsugu-Yokota Haruko Takeyama Haruko Takeyama Haruko Takeyama Haruko Takeyama Yoshimasa Takahashi |
spellingShingle |
Ryutaro Iwabuchi Ryutaro Iwabuchi Ryutaro Iwabuchi Keigo Ide Keigo Ide Kazutaka Terahara Ryota Wagatsuma Rieko Iwaki Hiroko Matsunaga Yasuko Tsunetsugu-Yokota Yasuko Tsunetsugu-Yokota Haruko Takeyama Haruko Takeyama Haruko Takeyama Haruko Takeyama Yoshimasa Takahashi Development of an Inflammatory CD14+ Dendritic Cell Subset in Humanized Mice Frontiers in Immunology humanized mice dendritic cell DC3 CD14 inflammatory response S100A8 |
author_facet |
Ryutaro Iwabuchi Ryutaro Iwabuchi Ryutaro Iwabuchi Keigo Ide Keigo Ide Kazutaka Terahara Ryota Wagatsuma Rieko Iwaki Hiroko Matsunaga Yasuko Tsunetsugu-Yokota Yasuko Tsunetsugu-Yokota Haruko Takeyama Haruko Takeyama Haruko Takeyama Haruko Takeyama Yoshimasa Takahashi |
author_sort |
Ryutaro Iwabuchi |
title |
Development of an Inflammatory CD14+ Dendritic Cell Subset in Humanized Mice |
title_short |
Development of an Inflammatory CD14+ Dendritic Cell Subset in Humanized Mice |
title_full |
Development of an Inflammatory CD14+ Dendritic Cell Subset in Humanized Mice |
title_fullStr |
Development of an Inflammatory CD14+ Dendritic Cell Subset in Humanized Mice |
title_full_unstemmed |
Development of an Inflammatory CD14+ Dendritic Cell Subset in Humanized Mice |
title_sort |
development of an inflammatory cd14+ dendritic cell subset in humanized mice |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2021-03-01 |
description |
Humanized mouse models are attractive experimental models for analyzing the development and functions of human dendritic cells (DCs) in vivo. Although various types of DC subsets, including DC type 3 (DC3s), have been identified in humans, it remains unclear whether humanized mice can reproduce heterogeneous DC subsets. CD14, classically known as a monocyte/macrophage marker, is reported as an indicator of DC3s. We previously observed that some CD14+ myeloid cells expressed CD1c, a pan marker for bona fide conventional DC2 (cDC2s), in humanized mouse models in which human FLT3L and GM-CSF genes were transiently expressed using in vivo transfection (IVT). Here, we aimed to elucidate the identity of CD14+CD1c+ DC-like cells in humanized mouse models. We found that CD14+CD1c+ cells were phenotypically different from cDC2s; CD14+CD1c+ cells expressed CD163 but not CD5, whereas cDC2s expressed CD5 but not CD163. Furthermore, CD14+CD1c+ cells primed and polarized naïve CD4+ T cells toward IFN-γ+ Th1 cells more profoundly than cDC2s. Transcriptional analysis revealed that CD14+CD1c+ cells expressed several DC3-specific transcripts, such as CD163, S100A8, and S100A9, and were clearly segregated from cDC2s and monocytes. When lipopolysaccharide was administered to the humanized mice, the frequency of CD14+CD1c+ cells producing IL-6 and TNF-α was elevated, indicating a pro-inflammatory signature. Thus, humanized mice are able to sustain development of functional CD14+CD1c+ DCs, which are equivalent to DC3 subset observed in humans, and they could be useful for analyzing the development and function of DC3s in vivo. |
topic |
humanized mice dendritic cell DC3 CD14 inflammatory response S100A8 |
url |
https://www.frontiersin.org/articles/10.3389/fimmu.2021.643040/full |
work_keys_str_mv |
AT ryutaroiwabuchi developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice AT ryutaroiwabuchi developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice AT ryutaroiwabuchi developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice AT keigoide developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice AT keigoide developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice AT kazutakaterahara developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice AT ryotawagatsuma developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice AT riekoiwaki developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice AT hirokomatsunaga developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice AT yasukotsunetsuguyokota developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice AT yasukotsunetsuguyokota developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice AT harukotakeyama developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice AT harukotakeyama developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice AT harukotakeyama developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice AT harukotakeyama developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice AT yoshimasatakahashi developmentofaninflammatorycd14dendriticcellsubsetinhumanizedmice |
_version_ |
1724220932190371840 |